The centralized procurement policy has swept across the country, and the consistency evaluation of chemical drugs has been normalized. The ninth batch of nationally purchased injection varieties accounted for the highest proportion, and more and more injection varieties have entered the national procurement. With fierce market competition and increasing demand for clinical applications, complex injections have emerged. There are few types, high technical barriers, and a huge market size, which makes pharmaceutical companies rush to join this army of drug research and development.

Challenges and opportunities coexist. How to break through technical barriers and improve conversion efficiency is worthy of in-depth consideration by enterprises. On August 15-16, 2024, the Pharmaceutical Fusion Circle will hold the "Injections Conference" at the same time as the CMC China Expo, focusing on the research and development and production technology of injections. Experts will help you decipher the problems of sterile production and provide one-stop solutions to complex injection technology application solutions!